Latest Search
Quote
| Back Zoom + Zoom - | |
|
<Hindsight>Brokers' Latest Ratings, TPs & Views on MEITUAN-W Post-Results
Recommend 29 Positive 61 Negative 30 |
|
|
|
|
MEITUAN-W (03690.HK) announced its 2025 results after the market closed yesterday. Our reporters have summarized the latest ratings and target prices for MEITUAN-W from eight brokers. Broker│Investment Rating│Target Price (HKD) CLSA│Outperform│135->120 Morgan Stanley│Overweight│120 Goldman Sachs│Buy│112 Nomura│Neutral│107 BofA Securities│Neutral│106 Citi│Neutral│94 UOB Kay Hian│Sell│79->74 Haitong Int'l│Neutral│84 Brokerage│View CLSA│Focus on quality growth, with slowed revenue growth but boosted earnings Morgan Stanley│Signs of recovery increased in 1Q26 Goldman Sachs│Results broadly in line with the profit alert, with unit economy expected to improve in 1Q26 Nomura│Losses narrowed in 1Q26, but full-year visibility still limited BofA Securities│Results in line, with core local businesses expected to trim its loss in 1Q26 due to eased subsidy pressure Citi│4Q25 revenue in line, with core local commercial loss at RMB10 billion and new business loss deepening to RMB4.6 billion UOB Kay Hian│Quarterly earnings missed, but management expects F&B delivery loss to halve QoQ in 1Q26, though visibility remains limited Haitong Int'l│Core local commercial revenue slightly missed, but new business revenue mildly beat AAStocks Financial News |
|
